Citadel Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Sell |
332,325
-2,598,708
| -89% | -$112M | ﹤0.01% | 1155 |
|
|
2025
Q1 | $101M | Buy |
2,931,033
+1,675,672
| +133% | +$57.9M | 0.02% | 262 |
|
|
2024
Q4 | $34.4M | Sell |
1,255,361
-1,686,753
| -57% | -$46.3M | 0.01% | 692 |
|
|
2024
Q3 | $74.9M | Buy |
2,942,114
+785,665
| +36% | +$20M | 0.01% | 339 |
|
|
2024
Q2 | $54.6M | Buy |
2,156,449
+1,273,174
| +144% | +$32.2M | 0.01% | 442 |
|
|
2024
Q1 | $27.3M | Buy |
883,275
+219,120
| +33% | +$6.78M | 0.01% | 743 |
|
|
2023
Q4 | $26.8M | Buy |
664,155
+95,495
| +17% | +$3.86M | 0.01% | 725 |
|
|
2023
Q3 | $15M | Buy |
568,660
+155,050
| +37% | +$4.09M | ﹤0.01% | 927 |
|
|
2023
Q2 | $7.11M | Buy |
413,610
+126,878
| +44% | +$2.18M | ﹤0.01% | 1445 |
|
|
2023
Q1 | $4.75M | Sell |
286,732
-2,590,456
| -90% | -$42.9M | ﹤0.01% | 1854 |
|
|
2022
Q4 | $21.9M | Buy |
2,877,188
+1,066,176
| +59% | +$8.12M | 0.01% | 824 |
|
|
2022
Q3 | $18M | Buy |
1,811,012
+969,218
| +115% | +$9.63M | ﹤0.01% | 899 |
|
|
2022
Q2 | $7.64M | Buy |
841,794
+455,732
| +118% | +$4.14M | ﹤0.01% | 1481 |
|
|
2022
Q1 | $3.92M | Buy |
+386,062
| New | +$3.92M | ﹤0.01% | 2303 |
|
|
2021
Q4 | – | Sell |
-342,548
| Closed | -$16.1M | – | 6454 |
|
|
2021
Q3 | $16.1M | Sell |
342,548
-70,030
| -17% | -$3.28M | ﹤0.01% | 1064 |
|
|
2021
Q2 | $25.2M | Buy |
412,578
+227,093
| +122% | +$13.8M | 0.01% | 823 |
|
|
2021
Q1 | $11.4M | Sell |
185,485
-48,798
| -21% | -$3.01M | ﹤0.01% | 1341 |
|
|
2020
Q4 | $16.7M | Buy |
234,283
+120,665
| +106% | +$8.58M | ﹤0.01% | 958 |
|
|
2020
Q3 | $4.26M | Buy |
113,618
+66,634
| +142% | +$2.5M | ﹤0.01% | 1624 |
|
|
2020
Q2 | $1.53M | Buy |
46,984
+14,616
| +45% | +$477K | ﹤0.01% | 2463 |
|
|
2020
Q1 | $939K | Buy |
+32,368
| New | +$939K | ﹤0.01% | 2929 |
|
|
2019
Q3 | – | Sell |
-22,281
| Closed | -$601K | – | 4661 |
|
|
2019
Q2 | $601K | Buy |
+22,281
| New | +$601K | ﹤0.01% | 3379 |
|